Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
Post market registry to assess the safety and efficacy of a novel decellularized human femoral artery allograft (Nexeon AVX Decellularized Femoral Artery,
Be male or female, ≥18 years of age at the time of graft placement [+4]
Be participating in a study of another investigational drug or device [+5]